Habitual, toxic, and lethal concentrations of 103 drugs of abuse in humans

Journal of Toxicology - Clinical Toxicology

Volumn 35, Issue 1, 1997, Pages 1-9

  Repetto, M Rosario ^a   Repetto, Manuel ^a  

^a Biology Section Apdo 863 E 41080   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; ALFENTANIL; AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BUSPIRONE; CENTRAL STIMULANT AGENT; CODEINE; FENTANYL; LORAZEPAM; LYSERGIDE; METHADONE; METHAQUALONE; MORPHINE; NALOXONE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXAZEPAM; PHENFORMIN; PHENOBARBITAL; PINDOLOL; PSYCHOTROPIC AGENT; SULPIRIDE; TIAPRIDE; UNINDEXED DRUG; ZOMEPIRAC; ZOPICLONE;

ARTICLE; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG TISSUE LEVEL; DRUG URINE LEVEL; HUMAN;

EID: 0031056039     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563659709001158     Document Type: Article

References (20)

1. Stead AH, Moffat AC. A collection of therapeutic, toxic and fatal blood drug concentrations in man. Hum Toxicol 1983;2:437-464.
2. Osselton MD. Toxicological tables: a compendium of pharmacological, therapeutic, and toxicological data on 137 drugs and chemicals in humans. In: Methodology for Analytical Toxicology, Volume III. Sunshine I, ed., Florida: Franklin Book Company, 1985:245-261.
3. Repetto M. El análisis químico-toxicológico. In: Toxicología Fundamental, 2 ed. Barcelona: Ed Científico-médica, 1988:344-366.
4. DiMaio DJ, DiMaio VJM. Interpretative toxicology: Drug abuse and drug deaths. In: Forensic Pathology. New York: Elsevier, 1989:440-487.
5. Meyer FP. Indicative therapeutic and toxic drug concentrations in plasma: a tabulation. Int J Clin Pharmacol Ther 1994;32:71-81.
6. Winek CL. Drug and Chemical Blood-Level Data 1994, Pittsburgh, 1994.
7. Schulz M, Schmoldt A. [A compilation of therapeutic and toxic plasma drug concentrations.] Anaesthesist 1994;43:835-844.
8. Uges DRA. Therapeutic and toxic drug concentrations. The TIAF 1996;26:S1-S34.
9. Sharp ME. Inconsistencies in recent compilations of therapeutic drug levels. The TIAF Bulletin 1995;25: 11-13.
10. Jones GR. Compilations of therapeutic drug levels. The TIAF Bulletin 1995;25:15-18.
11. Baselt RC. Analytical Procedures for Therapeutic Drug Monitoring and Emergency Toxicology, 2nd ed. Massachusetts: PSG Publishing Company, 1987.
12. Baselt RC, Cravey RH. Disposition of Toxic Drugs and Chemicals in Man, 3rd ed. Chicago: Year Book Medical Publishers, 1989.
13. Baselt RC, Cravey RH. Disposition of Toxic Drugs and Chemicals in Man, 4th ed. Foster City, California: Chemical Toxicology Institute, 1995.
14. Moffat AC, Jackson JV, Moss MS, Widdop B. Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids, and Postmortem Materials, 2nd ed. London: The Pharmaceutical Press, 1986.
15. Gottschalk LA, Cravey RH. Toxicological and Pathological Studies on Psychoactive Drug-Involved Deaths. California: Biomedical Publications, 1980.
16. Poisindex®, Toxicology Information, Micromedex Computerized Clinical Information System, International Healthcare Series, Micromedex Inc., 1996.
17. Ekwall B, Clemedson C, Hallander S, Bondesson I, Crafoord B. Goals, execution and present results of the MEMO programme. Abstracts of the XVII International Congress of the European Association of Poisons Centres and Clinical Toxicologists, Marseille, 1996; 201.
18. Pounder DJ, Jones GR. Postmortem drug redistribution - a toxicological nightmare. Forensic Sci Int 1990;45:253-263.
19. Prouty RW, Anderson WH. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci 1990;35:243-270.
20. Jones GR, Pounder DJ. Site dependence of drug concentrations in postmortem blood-a case study. J Anal Toxicol 1987;11:186-190.